MedTrace Logo

Long Term Follow-up of Hippocampal DBS for Refractory Epilepsy

NCT03404128 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2021-08-18

No results posted yet for this study

Summary

Follow up of the patients at Ghent University Hospital treated with hippocampal DBS for refractory epilepsy.

Endpoints:

* Long term evaluation of the effects of hippocampal DBS on seizure frequency and cognition
* Evaluation of the satisfaction of patients and neurologist regarding the rechargeable DBS battery

Conditions

  • Refractory Epilepsy

Interventions

OTHER

Questionnaires

Questionnaire for patient: satisfaction regarding rechargeable DBS battery Questionnaire for neurologist: seizure frequency, satisfaction regarding rechargeable DBS battery

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Paul Boon, MD, PhD · UZ Gent

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-11
Primary Completion
2021-04-20
Completion
2021-04-20

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03404128 on ClinicalTrials.gov